Net interest income has experienced a sharp 82% year-over-year contraction, falling from $943.5K in 2024Q3 to $107.4K by 2026Q1, reflecting the entity's inability to sustain its interest-bearing asset base.
| Net Interest Income | 1.4M | 1.9M | 3.62M | 199.85K |
| NII Growth % | -238.91% | -47.59% | 1709.88% | - |
| Net Interest Margin % | 11.43% | 15.66% | 4.9% | 0.28% |
| Interest Income | 1.4M | 1.9M | 3.62M | 199.85K |
| Interest Expense | 0 | 0 | 0 | 0 |
| Loan Loss Provision | 0 | 0 | 0 | 0 |
| Non-Interest Income | -1.4M | -1.9M | -3.62M | -199.85K |
| Non-Interest Income % | - | - | - | - |
| Total Revenue | 0 | 0 | 0 | 0 |
| Revenue Growth % | 0% | - | - | - |
| Non-Interest Expense | 484.33K | 835.76K | 1.06M | 28.46K |
| Efficiency Ratio | - | - | - | - |
| Operating Income | -484.33K | -835.76K | -1.06M | -28.46K |
| Operating Margin % | - | - | - | - |
| Operating Income Growth % | - | 21.52% | -3642.23% | - |
| Pretax Income | 920.55K | 1.06M | 2.55M | 171.39K |
| Pretax Margin % | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% |
| Net Income | 920.55K | 1.06M | 2.55M | 171.39K |
| Net Margin % | - | - | - | - |
| Net Income Growth % | -53.54% | -58.47% | 1389.01% | - |
| Net Income (Continuing) | 920.55K | 1.06M | 2.55M | 171.39K |
| EPS (Diluted) | 0.88 | 0.17 | 0.28 | 0.02 |
| EPS Growth % | -23.68% | -39.29% | 1373.68% | - |
| EPS (Basic) | - | 0.17 | 0.28 | 0.02 |
| Diluted Shares Outstanding | 1.04M | 4.05M | 9.03M | 9.03M |
Going concern liquidity crisis
As reported in financial statements, AFJK's net interest income has experienced a sharp decline, falling from a peak of $943.5K in 2024Q3 to just $107.4K by 2026Q1, representing an 82% year-over-year contraction that highlights the entity's inability to sustain its interest-bearing asset base.
The consistent downward trajectory in net interest income suggests that the underlying capital base is being depleted to fund ongoing administrative overhead. Investors should monitor whether this trend indicates an exhaustion of the entity's ability to generate even minimal interest income before a potential liquidation event.
Based on the company's quarterly filings, the net interest margin has fluctuated significantly, reaching a low of 0.3% in 2023Q4 and a brief peak of 2.9% in 2025Q4, reflecting the instability inherent in a shell company lacking a stable, long-term asset-liability management strategy.
The erratic NIM behavior appears to be a byproduct of shrinking cash balances rather than active yield management. This volatility suggests that the entity lacks the scale or structural integrity to maintain consistent interest spreads, rendering traditional margin analysis largely irrelevant for this vehicle.
According to recent SEC filings, AFJK maintains an efficiency ratio that is effectively unmeasurable due to the absence of operational revenue, underscoring the firm's status as a pre-revenue shell rather than a functioning financial institution with scalable cost structures or meaningful operating leverage.
The lack of revenue generation means that every dollar spent on administrative and professional fees directly erodes the remaining capital. This structure implies that the entity is currently a cost-center with no path to operational efficiency until a business combination is successfully executed.
Data from the most recent quarterly reports indicates that the company's cash position has dwindled to $2,929, a figure that warrants further investigation into the entity's ability to meet its ongoing regulatory and listing obligations without immediate external capital support or sponsor intervention.
The extreme scarcity of liquid assets suggests that the company may be facing a critical going concern risk. Investors should be wary that the current financial profile may necessitate dilutive financing or a distressed merger, which could significantly impair the value of existing equity interests.
Quick answers to the most common questions about buying AFJK stock.
Aimei Health Technology Co., Ltd (AFJK) is profitable, generating $1.1M in net income for the fiscal year ending 2025.